Klein, D.F.#, Thase, M.E., Endicott, J., Adler, L., Glick, I., Kalali, A., Leventer, S., Mattes, J., Ross, P., Bystristsky, A. Improving Clinical Trials: American Society of Clinical Psychopharmacology Recommendations. Archives of General Psychiatry, 2002 March; 59(3): 272-8.
Hertzman, M, Adler, L.W.# , Arlen, B, Kern, M. Lisinopril May Augment Antidepressant Response. Journal of Clinical Psychopharmacology, 25(2005) 618-620
Keefe RSE.#, Bilder RM, Harvey, PD, Davis, SM, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Miller, DD, Canive, JM, Adler, LW, Mansschreck, TC, Swartz, M, Rosenheck, R, Perkins, DO, Walker, TM, Stroup TS, McEvoy, JP, Lieberman, JA. Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial. Neuropsychopharmacology, advanced online publication 19 April 2006, 1-14.
Books and Book Chapters
Hertzman M & Adler LW (2010) Clinical Trials in Psychopharmacology: A Better Brain 2nd edn. Wiley Press. West Sussex.
Adler LW (2010) "Genes, The Genome and Brain Tailored Drugs"; In: Hertzman M & Adler LW (2010) Clinical Trials in Psychopharmacology: A Better Brain 2nd edn. Wiley Press. West Sussex pp.43-56.
Adler, L.W. Alzheimer's Disease Prevention: Is Lithium Neuroprotective? Paper presented at American Association of Geriatric Psychiatry Annual Meeting, San Diego, CA, 2005.
Adler, LW.#, Zepp, H, Cerro, L. A Model for Integrating Clinical Trials in a Community Practice Setting. Presented at APA Institute for Psychiatric Services, San Diego, CA, 2005
Adler, L.W. Alzheimer's Disease: A Final Common Pathway for Genetic Risk, Vascular Risk, Mood Dysregulation and Energy Dysregulation. Presented at American Association of Geriatric Psychiatry Annual Meeting, Puerto Rico, 2006
Adler, L.W.#, Cerro L,and Zepp H. A Meta-Analysis of the Efficacy of Paroxetine vs. Placebo Utilizing the GlaxoSmithKline Clinical Trials Registry. Presented at APA Annual Meeting, Toronto,CA, 2006
Adler, L.W.#, Remission of Major Depressive Episodes on Paroxetine vs. Placebo in Elderly and Adult Subjects. Presented at American Association of Geriatric Psychiatry Annual Meeting, New Orleans, LA, 2007
Adler, L.W.#, Reducing the Medical and Financial Burden of Depressive Illness: A Plan for Improving Health Care Services. Presented at the American Psychiatric Association Annual Meeting, San Diego, CA, 2007
Adler L.W., Regenold WT, Lachner C, Martin C, John D, Nakkalupu S.
Valproate-Related Hyperammonemiain Older
Psychiatric Inpatients. Presented at the American Association of Geriatric Psychiatry, Orlando, FL, 2013
Adler L, Regenold WT, Doddi S. A catatonia model as dysregulated glutamatergic cortico-thalamo-cortico neurotransmission. Presented at CINP (International College of Neuropsychopharmacology) World Congress, Vancouver, Canada, June 2014